4.8 Article

USR-VS: a web server for large-scale prospective virtual screening using ultrafast shape recognition techniques

Journal

NUCLEIC ACIDS RESEARCH
Volume 44, Issue W1, Pages W436-W441

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw320

Keywords

-

Funding

  1. French Government Investissements d'Avenir program A*MIDEX grant [ANR-11-IDEX-0001-02]
  2. Chinese University of Hong Kong Direct Grant
  3. Research Grants Council of Hong Kong GRF Grant [414413, 4055008, 4055046]

Ask authors/readers for more resources

Ligand-based Virtual Screening (VS) methods aim at identifying molecules with a similar activity profile across phenotypic and macromolecular targets to that of a query molecule used as search template. VS using 3D similarity methods have the advantage of biasing this search toward active molecules with innovative chemical scaffolds, which are highly sought after in drug design to provide novel leads with improved properties over the query molecule (e.g. patentable, of lower toxicity or increased potency). Ultrafast Shape Recognition (USR) has demonstrated excellent performance in the discovery of molecules with previously-unknown phenotypic or target activity, with retrospective studies suggesting that its pharmacophoric extension (USRCAT) should obtain even better hit rates once it is used prospectively. Here we present USR-VS (http://usr.marseille.inserm.fr/), the first web server using these two validated ligand-based 3D methods for large-scale prospective VS. In about 2 s, 93.9 million 3D conformers, expanded from 23.1 million purchasable molecules, are screened and the 100 most similar molecules among them in terms of 3D shape and pharmacophoric properties are shown. USR-VS functionality also provides interactive visualization of the similarity of the query molecule against the hit molecules as well as vendor information to purchase selected hits in order to be experimentally tested.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available